Frequency of rehospitalization after hospitalization for suicidal ideation or suicidal behavior in patients with depression.

Depression Hospitalization for suicidal ideation or suicidal behavior Retrospective cohort study

Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
28 Jan 2020
Historique:
received: 23 01 2020
accepted: 25 01 2020
pubmed: 18 2 2020
medline: 18 2 2020
entrez: 17 2 2020
Statut: aheadofprint

Résumé

This study sought to: 1. determine the frequency of rehospitalization with diagnosis of suicidal ideation or suicide attempt (SI/SA) within a year and how often patients had multiple rehospitalizations; 2. identify the time period for which the risk of rehospitalization is highest; and 3. determine the characteristics of patients with multiple rehospitalizations. We conducted a retrospective cohort study of adults with depression using 4 US health claims databases. We defined hospitalization as an inpatient or emergency room visit with codes indicating a suicide attempt or suicidal thoughts using a validated algorithm. Rates of rehospitalization with SI or SA were analyzed together and separately, including multiple re-hospitalizations with SI/SA. Across all databases 121,065 patients were hospitalized with a diagnosis of SI/SA. Rates of rehospitalization within a year ranged from 7.96% to 11.24%. The risk of rehospitalization with SI/SA is highest during the first month. Nearly 50% of rehospitalizations occurred within 3 months after initial hospitalization. Patients with rehospitalization(s) had more anxiety disorders, sleep disorders and substance use disorders than patients without. Among patients with depression hospitalized for SI/SA, rehospitalization for SI/SA within a year is not uncommon. Risk of rehospitalization with a diagnosis of SI/SA is highest during the first month.

Identifiants

pubmed: 32062326
pii: S0165-1781(20)30153-0
doi: 10.1016/j.psychres.2020.112810
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112810

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors are employees of Janssen Research & Development, LLC and stockholders of Johnson & Johnson. No mention of any drugs in the manuscript.

Auteurs

M Soledad Cepeda (MS)

Epidemiology Dept. Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ 08560. Electronic address: scepeda@its.jnj.com.

Martijn Schuemie (M)

Epidemiology Dept. Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ 08560.

David M Kern (DM)

Epidemiology Dept. Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ 08560.

Jenna Reps (J)

Epidemiology Dept. Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ 08560.

Carla Canuso (C)

Neuroscience Dept. Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ 08560.

Classifications MeSH